Miscellaneous Archives:

ERIC Legal Center Chairman Calls on Congress to Address Litigation Abuse

Washington, D.C., December 2, 2025– Today, Glenn Butash, Chair of the Legal Center for The ERISA Industry Committee (ERIC), testified before the House Education and Workforce Committee’s Subcommittee on Health, Employment, Labor, and Pensions at a hearing titled “Pension Predators: Stopping Class Action Abuse Against Workers’ Retirement.”

Coalition Urges Court to Rein In Novel 401(k) Forfeiture Claims

Washington, D.C., December 1, 2025– Last Wednesday, The ERISA Industry Committee (ERIC) and its coalition allies filed an amicus brief with the U.S. Court of Appeals for the Eighth Circuit in Matula, Jr. v. Wells Fargo & Company (Matula), urging the court to uphold the lower court’s decision. 

ERIC Urges USPTO to Withdraw Patent Rule That Weakens Competition and Raises Drug Costs

Washington, D.C., November 17, 2025– The ERISA Industry Committee (ERIC) today urged the U.S. Patent and Trademark Office (USPTO) to withdraw a proposed rule revising procedures of the Patent Trial and Appeal Board (PTAB) saying the proposal contradicts President Trump’s stated priority to make prescription drugs more affordable for American patients. 

ERIC: Biosimilars Can Help Employers Lower Costs Without Compromising Care

Washington, D.C., November 14, 2025– In a new report released today by The ERISA Industry Committee (ERIC), a majority of member companies stated they would consider shifting away from the “Traditional Rebate Model” if they were able to achieve savings by including lower list price drugs like biosimilars on their formulary.

ERIC and More than 100 Groups: Don’t Repeat History, Enact PBM Reform

Washington, D.C., November 12, 2025– The ERISA Industry Committee (ERIC) and more than 100 stakeholder groups representing employers, workers, patients, providers, consumers, industry stakeholders, and more, today called on Congress to act with urgency to enact strong pharmacy benefit manager (PBM) reforms this year.